FDA approves AstraZeneca’s Calquence

1st November 2017 Uncategorised 0

AstraZeneca’s Calquence has been given a speedy green light in the US as a treatment for adults with mantle cell lymphoma.

More: FDA approves AstraZeneca’s Calquence
Source: News